Showing results (2991-3000 of 3,091) with videos related to
Sort By:
Pageof 310
Drug Safety|December 11, 2025
GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the NetherlandsRana Jajou, Eugène van Puijenbroek, Jetty Overbeek, et al.Drug Safety|December 5, 2025
Unsuspected Adverse Drug Reactions to Dermatologic Medications: An Epidemiological Hypothesis-Free Screening Study of Real-World Data in DenmarkThomas Delvin, Anette Bygum, Lars Christian Lund, et al.Drug Safety|September 15, 2012
How to improve communication for the safe use of medicines?: Discussions on social marketing and patient-tailored approaches at the annual meetings of the WHO Programme for International Drug MonitoringPriya Bahri, Mira Harrison-WoolrychDrug Safety|January 1, 1991
Deferoxamine (desferrioxamine). New toxicities for an old drugY Bentur, M McGuigan, G KorenDrug Safety|August 7, 2012
A pathway to improved prospective observational post-authorization safety studiesVictor A KiriDrug Safety|August 11, 2012
Safety monitoring of herb-drug interactions: a component of pharmacovigilanceSouad Skalli, Rachida Soulaymani BencheikhDrug Safety|November 10, 2012
Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)Jordi Castellsague, Nuria Riera-Guardia, Brian Calingaert, et al.Drug Safety|January 1, 1990
Could Swedish 'yellow cards' be substituted by E-coded summaries?C Jorup-Rönström, M Keisu, B E WiholmDrug Safety|August 1, 2020
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIREAbigél M Kolonics-Farkas, Martina Šterclová, Nesrin Mogulkoc, et al.Drug Safety|August 14, 2020
E-Learning in Pharmacovigilance: An Evaluation of Microlearning-Based Modules Developed by Uppsala Monitoring CentreAnna Hegerius, Pia Caduff-Janosa, Ruth Savage, et al.Pageof 310